• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Ocrevus

bullseye darts target
Pharma

Roche's high-dose version of Ocrevus flunks phase 3 trial

Roche had high hopes for its high dose version of multiple sclerosis powerhouse Ocrevus, but a trial of the new formulation has come up short.
Kevin Dunleavy Apr 2, 2025 3:26pm
Collage poster study of businessmen picture chart arrow goes up

MS meds send CNS market toward strongest growth in years

Mar 26, 2025 10:48am
Roche building

Roche's Vabysmo will rise above Eylea biosim threat, exec says

Oct 23, 2024 11:24am
Ocrevus

Roche doubles down with subcutaneous FDA nod for MS star Ocrevus

Sep 13, 2024 1:50pm
Roches headquarters in Basel sunset in the background

Sales for Roche's Vabysmo rise again, but momentum is stalled

Jul 25, 2024 11:45am
Ocrevus

Roche touts near-complete MS suppression for injectable Ocrevus

Apr 17, 2024 11:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings